Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

The Michael J Fox Foundation is offering one- to two-year grants for any Parkinson’s research that will develop or improve tools to identify mitochondrial biomarkers for the disease.

The goal of the initiative is to assist in the discovery of mitochondrial biomarkers to assess Parkinson’s diagnosis, patient stratification and disease progression. Any knowledge gained from the study will be applied to human biospecimens – biological material obtained for the purpose of research.

The deadline for submission of pre-proposals is 27 September 2017. Funding will be allocated in May 2018.

Last Month

Next Month

Go Back

Share this story

Comments

In my country

‘People believe a witch doctor will cure them’

We speak to the president of the MPDA

WEBINAR – Tune in for the Michael J Fox Foundation 2016 round-up

13-year-old redesigns Parkinson’s tulip, the international symbol of the condition

Winning design for Parkinson’s awareness T-shirt announced

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

Researchers in Germany conducted a survey to assess how people with Parkinson’s disease perceive and experience medical cannabis. As part of the study, the team analysed answers from more than 1,300 people with Parkinson’s. They found that 65% of participants who did not use medical cannabis were interested in it, but lacked knowledge and feared side effects. Around 8% of participants reported using cannabis; of these, 54% reported beneficial effects – including 40% who reported reduced pain. Professor Dr Carsten Buhmann, lead study investigator, said: “Our data confirm that Parkinson’s disease patients have a high interest in treatment with medicinal cannabis […]. The data reported here may help physicians decide which patients could benefit, which symptoms could be addressed, and which type of cannabinoid and route of administration might be suitable. “It has to be stressed, though, that our findings are based on subjective patient reports and that clinically appropriate…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

In my country

‘People believe a witch doctor will cure them’

Resources & Tools

WEBINAR – Tune in for the Michael J Fox Foundation 2016 round-up

Global update

13-year-old redesigns Parkinson’s tulip, the international symbol of the condition

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Grants offered to identify mitochondrial biomarkers

News

Author: Parkinson's Life editorsPublished: 24 August 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

In my country

‘People believe a witch doctor will cure them’

Resources & Tools

WEBINAR – Tune in for the Michael J Fox Foundation 2016 round-up

Global update

13-year-old redesigns Parkinson’s tulip, the international symbol of the condition

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Sign in